COI
AZN icon

Connable Office Inc’s AstraZeneca AZN Stock Holding History

Connable Office Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
5,848
-96
-2% -$18.1K 0.1% 88
2026
Q1 		$1.17M Buy
5,944
+183
+3% +$35.3K 0.12% 80
2025
Q4 		$1.06M Sell
5,761
-247
-4% -$43.3K 0.1% 89
2025
Q3 		$922K Hold
6,008
– – 0.09% 95
2025
Q2 		$840K Sell
6,008
-4,026
-40% -$564K 0.08% 101
2025
Q1 		$1.47M Sell
10,034
-555
-5% -$80.3K 0.16% 80
2024
Q4 		$1.39M Sell
10,589
-293
-3% -$41K 0.14% 81
2024
Q3 		$1.7M Hold
10,882
– – 0.17% 78
2024
Q2 		$1.7M Buy
10,882
+2,661
+32% +$400K 0.18% 78
2024
Q1 		$1.11M Sell
8,221
-280
-3% -$37.1K 0.13% 88
2023
Q4 		$1.15M Hold
8,501
– – 0.14% 86
2023
Q3 		$1.15M Buy
8,501
+21
+0.2% +$2.87K 0.16% 85
2023
Q2 		$1.21M Sell
8,480
-206
-2% -$30.3K 0.17% 82
2023
Q1 		$1.21M Hold
8,686
– – 0.18% 84
2022
Q4 		$1.18M Buy
8,686
+73
+0.8% +$9.15K 0.17% 84
2022
Q3 		$945K Buy
+8,613
New +$1.09M 0.15% 91
2014
Q2 		– Sell
-4,138
Closed -$268K – 216
2014
Q1 		$268K Sell
4,138
-742
-15% -$47.9K 0.07% 155
2013
Q4 		$290K Sell
4,880
-491
-9% -$26.7K 0.08% 147
2013
Q3 		$279K Hold
5,371
– – 0.08% 185
2013
Q2 		$254K Buy
+5,371
New +$273K 0.07% 186

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Connable Office Inc's AZN Position: Q2 2026 in Review

Connable Office Inc reduced its AstraZeneca (AZN) stake by 1.6% in Q2 2026, selling an estimated $18.1K and leaving 5,848 shares worth $1.11M. The position accounts for 0.1% of the portfolio, ranked #88.

Connable Office Inc first reported a position in AZN in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.7M in Q2 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Connable Office Inc held 5,848 shares of AstraZeneca worth $1.11M as of Q2 2026.
  • Connable Office Inc sold 96 AstraZeneca shares in Q2 2026, an estimated $18.1K.
  • AstraZeneca made up 0.1% of Connable Office Inc's portfolio in Q2 2026, its #88 holding.
  • Connable Office Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 20 quarters since.
  • Connable Office Inc's AstraZeneca position peaked at $1.7M in Q2 2024.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Connable Office Inc's 13F filing for Q2 2026, filed 3 Aug 2026.